Elevated factor VIII level: An implication for thrombosis during pregnancy
1 Department of Medical Laboratory Sciences, University of Nigeria Nsukka, Nigeria.
2 Department of Biochemistry, University of Uyo, Akwa Ibom State, Nigeria.
3 Department of Anatomic Pathology, Alex Ekwume Federal University, Ndufu-Alike, Nigeria.
4 Department of Public Health and Health Care, First Moscow State Medical University (I.M Sechenov University), Russia.
Review
Open Access Research Journal of Life Sciences, 2023, 06(01), 058–067.
Article DOI: 10.53022/oarjls.2023.6.1.0053
Publication history:
Received on 24 June 2023, revised on 02 August 2023, accepted on 05 August 2023
Abstract:
Hemostasis is the process by which the body maintains the integrity of blood vessels and regulates blood circulation. It involves arresting bleeding, and possibly mending broken or severed blood vessels. It is achieved through a series of steps, including vascular spasm, platelet plug formation, coagulation cascade, and fibrinolysis. Skipping any of these steps causes severe bleeding and death. During pregnancy, the hemostatic system undergoes significant changes to adapt to the physiological demands. These changes aim to prevent excessive bleeding during and after childbirth. Hypercoagulability, characterized by elevated clotting factors and reduced fibrinolytic activity, is common during pregnancy. While these alterations in the coagulation system help prevent postpartum bleeding, they also increase the mother's risk of thrombosis by a factor of five. This hypercoagulable state is caused by pregnancy-related factors like venous stasis, endothelial damage, and hormonal fluctuations. However, studies have shown that an increase in Factor VIII levels poses as a risk factor for both venous and arterial thrombosis. The determination of plasma factor VIII levels is influenced by genetic factors, as well as the levels of von Willebrand factor (VWF) and the individual's blood group. The findings of familial investigations have revealed that the concentration of factor VIII is indeed hereditary, exhibiting a lesser degree of variability among twins when compared with individuals who lack a familial connection. Continuous monitoring should be performed on pregnant patients with thrombosis risk factors. This intervention is implemented with the aim of mitigating the potential aggravation of deep vein thrombosis (DVT) and the subsequent development of post-thrombotic syndrome.
Keywords:
Hemostasis; Coagulation cascade; Hypercoagulability; Factor VIII; Thrombosis; Pregnancy
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0